TrianglePUBLICATIONS · 17602081
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2007 Jul 1
- First author
- Maki RG
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2007 Aug 20;25(24):3790
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
Authors and identifiers
- name
- Maki RG
- type
- Author
- name
- Wathen JK
- type
- Author
- name
- Patel SR
- type
- Author
- name
- Priebat DA
- type
- Author
- name
- Okuno SH
- type
- Author
- name
- Samuels B
- type
- Author
- name
- Fanucchi M
- type
- Author
- name
- Harmon DC
- type
- Author
- name
- Schuetze SM
- type
- Author
- name
- Reinke D
- type
- Author
- name
- Thall PF
- type
- Author
- name
- Benjamin RS
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Maki RG
- type
- Author
- name
- Wathen JK
- type
- Author
- name
- Patel SR
- type
- Author
- name
- Priebat DA
- type
- Author
- name
- Okuno SH
- type
- Author
- name
- Samuels B
- type
- Author
- name
- Fanucchi M
- type
- Author
- name
- Harmon DC
- type
- Author
- name
- Schuetze SM
- type
- Author
- name
- Reinke D
- type
- Author
- name
- Thall PF
- type
- Author
- name
- Benjamin RS
- type
- Author
- bibliography ids
- nci-bib-c2f1c006d99440f86519ba40
- book metadata
- content sha256
- af96aacd393706f7e90bd8578e651f974416c3ed88fae74c6cb2edecdfeb30ff
- document type
- citation
- dois
- 10.1200/JCO.2006.10.4117
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:17602081
- immutable id
- pubmed:17602081@af96aacd393706f7e90bd8578e651f974416c3ed88fae74c6cb2edecdfeb30ff
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2755-63
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2007 Aug 20;25(24):3790
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
- outcomes validated
- false
- pmid
- 17602081
- provenance
- batch id
- de363a11f4b1613edab0
- provider
- NCBI PubMed ESummary
- record sha256
- fb7cc64fe460dc48e742e8aeb9c9338d8ff32a9639bf3ae3cfbe8472dd120c28
- response sha256
- a83f066085229c55d3d0ec880c129c835ac872440e73f5fc2b7131ecfb2a254f
- retrieved at
- 2026-09-09T23:46:14.107379+00:00
- publication date
- display
- 2007 Jul 1
- precision
- day
- year
- 2007
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].
Preserved source evidence · Not medical advice